Cargando…
Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer
The failure of current chemotherapeutic agents for pancreatic cancer (PCa) makes it the most aggressive soft tissue tumor with a 5-year survival of slightly above 10% and is estimated to be the second leading cause of cancer death by 2030. Objective: The main aim was to synthesize, characterize and...
Autores principales: | Ndemazie, Nkafu Bechem, Inkoom, Andriana, Ebesoh, Dexter, Bulusu, Raviteja, Frimpong, Esther, Trevino, Jose, Han, Bo, Zhu, Xue, Agyare, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773620/ https://www.ncbi.nlm.nih.gov/pubmed/36550419 http://dx.doi.org/10.1186/s12885-022-10449-y |
Ejemplares similares
-
Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer
por: Ndemazie, Nkafu Bechem, et al.
Publicado: (2023) -
Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer
por: Inkoom, Andriana, et al.
Publicado: (2023) -
Multi-disciplinary Approach for Drug and Gene Delivery Systems to the Brain
por: Ndemazie, Nkafu Bechem, et al.
Publicado: (2021) -
Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
por: Inkoom, Andriana, et al.
Publicado: (2020) -
Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV/AIDS patients at a major referral centre in South-west Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2017)